Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Iovino

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Current Pharmaceutical Design|July 17, 2012
Vasopressin secretion control: central neural pathways, neurotransmitters and effects of drugsMichele Iovino, Edoardo Guastamacchia, Vito Angelo Giagulli, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|January 7, 2017
Synaptic Inputs of Neural Afferent Pathways to Vasopressin- and Oxytocin-Secreting Neurons of Supraoptic and Paraventricular Hypothalamic NucleiMichele Iovino, Vito Angelo Giagulli, Brunella Licchelli, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|April 13, 2021
Endocrine-Disrupting Chemicals: Introduction to the ThemeGiuseppe Lisco, Vito Angelo Giagulli, Michele Iovino, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|September 4, 2014
Sevelamer carbonate markedly reduces levothyroxine absorptionMichele Iovino, Nicola Iovine, Alfanso Petrosino, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|October 1, 2015
Hypopituitarism in Neurocritical Patients: A Case ReportMichele Iovino, Nicola Iovine, Fiorentino Mondillo, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|September 17, 2013
Role of central and peripheral chemoreceptors in vasopressin secretion controlMichele Iovino, Edoardo Guastamacchia, Vito Angelo Giagulli, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|August 17, 2018
Vigilance States: Central Neural Pathways, Neurotransmitters and NeurohormonesMichele Iovino, Tullio Messana, Giovanni De Pergola, et al.
Biomedicines|November 25, 2023
Dopamine in the Regulation of Glucose Homeostasis, Pathogenesis of Type 2 Diabetes, and Chronic Conditions of Impaired Dopamine Activity/Metabolism: Implication for Pathophysiological and Therapeutic PurposesGiuseppe Lisco, Anna De Tullio, Michele Iovino, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|February 2, 2019
Neuroendocrine Mechanisms Involved in Male Sexual and Emotional BehaviorMichele Iovino, Tullio Messana, Emanuela Iovino, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|April 10, 2014
Amiodarone-induced SIADH: two cases reportMichele Iovino, Nicola Iovine, Antonio Petrosino, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Current Pharmaceutical Design|July 17, 2012
Vasopressin secretion control: central neural pathways, neurotransmitters and effects of drugsMichele Iovino, Edoardo Guastamacchia, Vito Angelo Giagulli, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|January 7, 2017
Synaptic Inputs of Neural Afferent Pathways to Vasopressin- and Oxytocin-Secreting Neurons of Supraoptic and Paraventricular Hypothalamic NucleiMichele Iovino, Vito Angelo Giagulli, Brunella Licchelli, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|April 13, 2021
Endocrine-Disrupting Chemicals: Introduction to the ThemeGiuseppe Lisco, Vito Angelo Giagulli, Michele Iovino, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|September 4, 2014
Sevelamer carbonate markedly reduces levothyroxine absorptionMichele Iovino, Nicola Iovine, Alfanso Petrosino, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|October 1, 2015
Hypopituitarism in Neurocritical Patients: A Case ReportMichele Iovino, Nicola Iovine, Fiorentino Mondillo, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|September 17, 2013
Role of central and peripheral chemoreceptors in vasopressin secretion controlMichele Iovino, Edoardo Guastamacchia, Vito Angelo Giagulli, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|August 17, 2018
Vigilance States: Central Neural Pathways, Neurotransmitters and NeurohormonesMichele Iovino, Tullio Messana, Giovanni De Pergola, et al.
Biomedicines|November 25, 2023
Dopamine in the Regulation of Glucose Homeostasis, Pathogenesis of Type 2 Diabetes, and Chronic Conditions of Impaired Dopamine Activity/Metabolism: Implication for Pathophysiological and Therapeutic PurposesGiuseppe Lisco, Anna De Tullio, Michele Iovino, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|February 2, 2019
Neuroendocrine Mechanisms Involved in Male Sexual and Emotional BehaviorMichele Iovino, Tullio Messana, Emanuela Iovino, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|April 10, 2014
Amiodarone-induced SIADH: two cases reportMichele Iovino, Nicola Iovine, Antonio Petrosino, et al.
Pageof 3